Out of 7 analysts covering SunOpta (NASDAQ:STKL), 5 rate it “Buy”, 0 “Sell”, while 3 “Hold”. This means 63% are positive. SunOpta was the topic in 6 analyst reports since August 15, 2015 according to StockzIntelligence Inc. Below is a list of SunOpta, Inc. (USA) (NASDAQ:STKL) latest ratings and price target changes.
09/12/2015 Broker: Citigroup Rating: Buy Old Target: $11.00 New Target: $8.50 Target Down
08/10/2015 Broker: BMO Capital Markets Rating: Outperform New Target: $7.00 Initiate
The stock closed at $4.6 during the last session. It is down 48.60% since August 27, 2015 and is downtrending. It has underperformed by 52.55% the S&P500.
Sunopta Inc. is a global company operating businesses focused on healthy products portfolio. The company has a market cap of $409.47 million. The Firm specializes in sourcing, processing and packaging of natural, organic and specialty food products. It currently has negative earnings. It operates in three divisions: Global Ingredients, Consumer Products and Opta Minerals.
The institutional sentiment increased to 1.22 in 2015 Q3. Its up 0.11, from 1.11 in 2015Q2. The ratio is positive, as 27 funds sold all SunOpta, Inc. (USA) shares owned while 24 reduced positions. 20 funds bought stakes while 42 increased positions. They now own 72.50 million shares or 36.67% more from 53.05 million shares in 2015Q2.
West Face Capital Inc. holds 17.05% of its portfolio in SunOpta, Inc. (USA) for 8.47 million shares. Domini Social Investments Llc owns 81,596 shares or 6.49% of their US portfolio. Moreover, Daruma Capital Management Llc has 1.99% invested in the company for 6.68 million shares. The New York-based Overbrook Management Corp has invested 1.63% in the stock. Rock Point Advisors Llc, a Vermont-based fund reported 473,777 shares.
SunOpta, Inc. - Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with MarketBeat.com’s FREE daily email newsletter.